DrugPatentWatch Database Preview
Drugs in Development Information for Bitopertin
Email this page to a colleague
What is the drug development status for Bitopertin?
Bitopertin is an investigational drug.
There have been 10 clinical trials for Bitopertin.
The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2010.
The most common disease conditions in clinical trials are Schizophrenia, Disease, and Compulsive Personality Disorder. The leading clinical trial sponsors are Hoffmann-La Roche, Niuvanniemi Hospital, and Karolinska Institutet.
Summary for Bitopertin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 129 |
| WIPO Patent Applications | 80 |
| Japanese Patent Applications | 38 |
| Clinical Trial Progress | Phase 3 (2010-12-01) |
| Vendors | 52 |
Recent Clinical Trials for Bitopertin
| Title | Sponsor | Phase |
|---|---|---|
| A Study of Bitopertin (RO4917838) in Adults With Non-Transfusion-Dependent Beta-Thalassemia | Hoffmann-La Roche | Phase 2 |
| A Study Exmining the Effect of Multiple Doses of Bitopertin on the Single Dose Pharmacokinetics of Midazolam in Healthy Volunteers. | Hoffmann-La Roche | Phase 1 |
| Sodium Benzoate for Treatment of Attenuated/Transient Psychosis. A Randomized Placebo-controlled Trial. | Karolinska Institutet | Phase 2 |
Clinical Trial Summary for Bitopertin
Top disease conditions for Bitopertin
Top clinical trial sponsors for Bitopertin
US Patents for Bitopertin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
